{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:44:17Z","timestamp":1789937057699,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10147-018-1282-7","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T09:37:42Z","timestamp":1525858662000},"page":"1013-1019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Current clinical topics of Lynch syndrome"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-6911","authenticated-orcid":false,"given":"Kohji","family":"Tanakaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"1282_CR1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/archinte.1913.00070050063006","volume":"12","author":"AS Warthin","year":"1913","unstructured":"Warthin AS (1913) Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895\u20131913. Arch Int Med 12:546\u2013555","journal-title":"Arch Int Med"},{"key":"1282_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/archinte.1966.03870080050009","volume":"117","author":"HT Lynch","year":"1966","unstructured":"Lynch HT, Shaw MW, Magnuson CW et al (1966) Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 117:206\u2013212","journal-title":"Arch Intern Med"},{"key":"1282_CR3","unstructured":"Kohlmann W, Gruber SB (2004) Lynch syndrome. Gene Reviews. AVAILABLE via DIALOG. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1211\/ . Accessed Apr 2018"},{"key":"1282_CR4","unstructured":"InSiGHT (2018) Available via DIALOG. https:\/\/www.insight-group.org\/ . Accessed Apr 2018"},{"key":"1282_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/jjco\/hyw178","volume":"47","author":"N Chika","year":"2017","unstructured":"Chika N, Eguchi H, Kumamoto K et al (2017) Prevalence of LS and Lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population. Jpn J Clin Oncol 47:108\u2013117","journal-title":"Jpn J Clin Oncol"},{"key":"1282_CR6","doi-asserted-by":"crossref","unstructured":"Jensen LH, Bojesen A, Byriel L et al (2013) Implementing population-based screening for Lynch syndrome. J Clin Oncol 31(Suppl):abstr 6600. https:\/\/meetinglibrary.asco.org\/record\/84519\/poster . Accessed Apr 2018","DOI":"10.1200\/jco.2013.31.15_suppl.6600"},{"key":"1282_CR7","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","volume":"26","author":"H Hampel","year":"2008","unstructured":"Hampel H, Frankel WL, Martin E et al (2008) Feasibility of screening for LS among patients with colorectal cancer. J Clin Oncol 26:5783\u20135788","journal-title":"J Clin Oncol"},{"key":"1282_CR8","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2012.13088","volume":"308","author":"L Moreira","year":"2012","unstructured":"Moreira L, Balaguer F, Lindor N et al (2012) Identification of Lynch syndrome among patients with colorectal cancer. JAMA 308:1555\u20131565","journal-title":"JAMA"},{"key":"1282_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10689-016-9882-8","volume":"15","author":"P Peltom\u00e4ki","year":"2016","unstructured":"Peltom\u00e4ki P (2016) Update on Lynch syndrome genomics. Fam Cancer 15:385\u2013393","journal-title":"Fam Cancer"},{"key":"1282_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ng.283","volume":"41","author":"MJ Ligtenberg","year":"2009","unstructured":"Ligtenberg MJ, Kuiper RP, Chan TL et al (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\u2032 exons of TACSTD1. Nat Genet 41:112\u2013117","journal-title":"Nat Genet"},{"key":"1282_CR11","doi-asserted-by":"crossref","unstructured":"Ishida H, Yamaguchi T, Tanakaya K et al (2018) Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version). J Anus Rectum Colon (JARC). http:\/\/journal-arc.jp\/pdf\/002s10001.pdf . Accessed Apr 2018","DOI":"10.23922\/jarc.2017-028"},{"key":"1282_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar A, Boland CR, Terdiman JP et al (2004) Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch Syndrome) and microsatellite instability. J Natl Cancer Inst 96:261\u2013268","journal-title":"J Natl Cancer Inst"},{"key":"1282_CR13","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN guidelines). Genetic\/Familial High-Risk Assessment: Colorectal Version 3.2017. http:\/\/www.nccn.org . Accessed Feb 2018"},{"key":"1282_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1053\/j.gastro.2014.04.001","volume":"147","author":"FM Giardiello","year":"2014","unstructured":"Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 147:502\u2013526","journal-title":"Gastroenterology"},{"key":"1282_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/jjco\/hyu190","volume":"45","author":"T Yamaguchi","year":"2014","unstructured":"Yamaguchi T, Furukawa Y, Nakamura Y et al (2014) Comparison of clinical features between suspected familial colorectal cancer type X and LS in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum. Jpn J Clin Oncol 45:153\u2013159","journal-title":"Jpn J Clin Oncol"},{"key":"1282_CR16","first-page":"1985","volume":"36","author":"K Tanakaya","year":"2016","unstructured":"Tanakaya K, Yamaguchi T, Ishikawa H et al (2016) Causes of cancer death among first-degree relatives in Japanese families with Lynch syndrome. Anticancer Res 36:1985\u20131989","journal-title":"Anticancer Res"},{"key":"1282_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/BF02053699","volume":"34","author":"HF Vasen","year":"1991","unstructured":"Vasen HF, Mecklin JP, Khan PM et al (1991) The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34:424\u2013425","journal-title":"Dis Colon Rectum"},{"key":"1282_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","volume":"11","author":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group","year":"2009","unstructured":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group (2009) Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35\u201341","journal-title":"Genet Med"},{"key":"1282_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2004.07.017","volume":"216","author":"T Ishikubo","year":"2004","unstructured":"Ishikubo T, Nishimura Y, Yamaguchi K et al (2004) The clinical features of rectal cancers with high-frequency microsatellite instability (MSI-H) in Japanese males. Cancer Lett 216:55\u201362","journal-title":"Cancer Lett"},{"key":"1282_CR20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/carcin\/bgp017","volume":"30","author":"S Asaka","year":"2009","unstructured":"Asaka S, Arai Y, Nishimura Y et al (2009) Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes\u2019 A to Dukes\u2019 B. Carcinogenesis 30:494\u2013499","journal-title":"Carcinogenesis"},{"key":"1282_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/ijc.11523","volume":"108","author":"K Koinuma","year":"2004","unstructured":"Koinuma K, Shitoh K, Miyakura Y et al (2004) Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas. Int J Cancer 108:237\u2013242","journal-title":"Int J Cancer"},{"key":"1282_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/B:FAME.0000039861.30651.c8","volume":"3","author":"A McGivern","year":"2004","unstructured":"McGivern A, Wynter CV, Whitehall VL et al (2004) Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non\u2013polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 3:101\u2013110","journal-title":"Fam Cancer"},{"key":"1282_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/PAS.0b013e31826485c0","volume":"37","author":"GV Long","year":"2013","unstructured":"Long GV, Wilmott JS, Capper D et al (2013) Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma. Am J Surg Pathol 37:61\u201365","journal-title":"Am J Surg Pathol"},{"key":"1282_CR24","first-page":"1541","volume":"34","author":"M Kawaguchi","year":"2009","unstructured":"Kawaguchi M, Yanokura M, Banno K et al (2009) Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer. Int J Oncol 34:1541\u20131547","journal-title":"Int J Oncol"},{"key":"1282_CR25","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H et al (2015) PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med 372:2509\u20132520","journal-title":"N Engl J Med"},{"key":"1282_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/jmedgenet-2011-100082","volume":"48","author":"AK Win","year":"2011","unstructured":"Win AK, Jenkins MA, Buchanan DD et al (2011) Determining the frequency of de novo germline mutations in DNA mismatch repair genes. J Med Genet 48:530\u2013534","journal-title":"J Med Genet"},{"key":"1282_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/cge.12529","volume":"87","author":"G Ponti","year":"2015","unstructured":"Ponti G, Castellsagu\u00e9 E, Ruini C et al (2015) Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome. Clin Genet 87:507\u2013516","journal-title":"Clin Genet"},{"key":"1282_CR28","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1136\/jmg.40.3.e30","volume":"40","author":"I Sumitsuji","year":"2003","unstructured":"Sumitsuji I, Sugano K, Matsui T et al (2003) Frequent genomic disorganisation of MLH1 in hereditary non-polyposis colorectal cancer (HNPCC) screened by RT-PCR on puromycin treated samples. J Med Genet 40:e30","journal-title":"J Med Genet"},{"key":"1282_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12957-017-1207-3","volume":"15","author":"M Utsumi","year":"2017","unstructured":"Utsumi M, Tanakaya K, Mushiake Y et al (2017) Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a LS patient: a case report. World J Surg Oncol 15:140","journal-title":"World J Surg Oncol"},{"key":"1282_CR30","first-page":"2","volume":"17","author":"Y Furukawa","year":"2013","unstructured":"Furukawa Y (2013) Genetic changes of Japanese Lynch syndrome (in Japanese). Intestine 17:2\u20135","journal-title":"Intestine"},{"key":"1282_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jmoldx.2012.03.002","volume":"14","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Smith C, Salipante SJ et al (2012) ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn 14:357\u2013366","journal-title":"J Mol Diagn"},{"key":"1282_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1053\/j.gastro.2015.05.006","volume":"149","author":"MB Yurgelun","year":"2015","unstructured":"Yurgelun MB, Allen B, Kaldate RR et al (2015) Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch Syndrome. Gastroenterology 149:604\u2013613","journal-title":"Gastroenterology"},{"key":"1282_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/gim.2014.134","volume":"17","author":"AR Bradbury","year":"2015","unstructured":"Bradbury AR, Patrick-Miller L, Long J et al (2015) Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility. Genet Med 17:485\u2013492","journal-title":"Genet Med"},{"key":"1282_CR34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ejca.2013.12.005","volume":"50","author":"D Bakry","year":"2014","unstructured":"Bakry D, Aronson M, Durno C et al (2014) Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer 50:987\u2013996","journal-title":"Eur J Cancer"},{"key":"1282_CR35","doi-asserted-by":"publisher","first-page":"9253","DOI":"10.3748\/wjg.v21.i31.9253","volume":"21","author":"JM Carethers","year":"2015","unstructured":"Carethers JM, Stoffel EM (2015) Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. World J Gastroenterol 21:9253\u20139261","journal-title":"World J Gastroenterol"},{"key":"1282_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00439-008-0542-4","volume":"124","author":"K Wimmer","year":"2008","unstructured":"Wimmer K, Etzler J (2008) Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet 124:105\u2013122","journal-title":"Hum Genet"},{"key":"1282_CR37","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1053\/j.gastro.2017.03.013","volume":"152","author":"Q Rana","year":"2017","unstructured":"Rana Q, Syngal HS (2017) Biallelic mismatch repair deficiency: management and prevention of a devastating manifestation of the Lynch syndrome. Gastroenterology 152:1254\u20131257","journal-title":"Gastroenterology"},{"key":"1282_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajhg.2016.06.015","volume":"99","author":"R Adam","year":"2016","unstructured":"Adam R, Spier I, Zhao B et al (2016) Exome sequencing identifies biallelic MSH3 germline mutations as a recessive subtype of colorectal adenomatous polyposis. Am J Hum Genet 99:337\u2013351","journal-title":"Am J Hum Genet"},{"key":"1282_CR39","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1053\/j.gastro.2017.02.011","volume":"152","author":"C Durno","year":"2017","unstructured":"Durno C, Boland CR, Cohen S et al (2017) Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2017 152:1605\u20131614","journal-title":"Gastroenterology"},{"key":"1282_CR40","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1053\/j.gastro.2013.01.044","volume":"144","author":"M Rodr\u00edguez-Soler","year":"2013","unstructured":"Rodr\u00edguez-Soler M, P\u00e9rez-Carbonell L, Guarinos C et al (2013) Risk of cancer in cases of suspected lynch syndrome without germline mutation. Gastroenterology 144:926\u2013932","journal-title":"Gastroenterology"},{"key":"1282_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.humpath.2017.10.022","volume":"70","author":"JL Dillon","year":"2017","unstructured":"Dillon JL, Gonzalez JL, DeMars L et al (2017) Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Hum Pathol 70:121\u2013128","journal-title":"Hum Pathol"},{"key":"1282_CR42","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","volume":"116","author":"HF Vasen","year":"1999","unstructured":"Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453\u20131456","journal-title":"Gastroenterology"},{"key":"1282_CR43","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1001\/jama.293.16.1979","volume":"293","author":"NM Lindor","year":"2005","unstructured":"Lindor NM, Rabe K, Petersen GM et al. (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293:1979\u20131985","journal-title":"JAMA"},{"key":"1282_CR44","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/cge.12427","volume":"87","author":"P Garre","year":"2015","unstructured":"Garre P, Martin L, Sanz J et al (2015) BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X. Clin Genet 87:582\u2013587","journal-title":"Clin Genet"},{"key":"1282_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/modpathol.2014.49","volume":"28","author":"M Dominguez-Valentin","year":"2014","unstructured":"Dominguez-Valentin M, Therkildsen C, Da Silva S et al (2014) Familial colorectal cancer type X: genetic profiles and phenotypic features. Mod Pathol 28:30\u201336","journal-title":"Mod Pathol"},{"key":"1282_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.currproblcancer.2017.10.002","volume":"41","author":"M Nejadtaghi","year":"2017","unstructured":"Nejadtaghi M, Jafari H, Farrohki E et al (2017) Familial Colorectal Cancer Type X (FCCTX) and the correlation with various genes-A systematic review. Curr Probl Cancer 41:388\u2013397","journal-title":"Curr Probl Cancer"},{"key":"1282_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ng.2503","volume":"45","author":"C Palles","year":"2013","unstructured":"Palles C, Cazier JB, Howarth KM et al (2013) Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 45:136\u2013144","journal-title":"Nat Genet"},{"key":"1282_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.4185","volume":"230","author":"S Briggs","year":"2013","unstructured":"Briggs S, Tomlinson I (2013) Germline and somatic polymerase \u03b5 and \u03b4 mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol 230:148\u2013153","journal-title":"J Pathol"},{"key":"1282_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ng.2540","volume":"45","author":"S Seshagiri","year":"2013","unstructured":"Seshagiri S (2013) The burden of faulty proofreading in colon cancer. Nat Genet 45:121\u2013122","journal-title":"Nat Genet"},{"key":"1282_CR50","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.critrevonc.2017.03.027","volume":"113","author":"R Bourdais","year":"2017","unstructured":"Bourdais R, Rousseau B, Pujals A et al (2017) Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency. Crit Rev Oncol Hematol 113:242\u2013248","journal-title":"Crit Rev Oncol Hematol"},{"key":"1282_CR51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","volume":"118","author":"HJ J\u00e4rvinen","year":"2000","unstructured":"J\u00e4rvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829\u2013834","journal-title":"Gastroenterology"},{"key":"1282_CR52","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","volume":"62","author":"HF Vasen","year":"2013","unstructured":"Vasen HF, Blanco I, Aktan-Collan K et al (2013) Revised guidelines for the clinical management of LS (HNPCC): recommendations by a group of European experts. Gut 62:812\u2013823","journal-title":"Gut"},{"key":"1282_CR53","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/gut.2010.228056","volume":"60","author":"S Parry","year":"2011","unstructured":"Parry S, Win AK, Parry B, et.al (2011) Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 60:950\u2013957","journal-title":"Gut"},{"key":"1282_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJMoa052627","volume":"354","author":"KM Schmeler","year":"2006","unstructured":"Schmeler KM, Lynch HT, Chem LM et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354:261\u2013269","journal-title":"N Engl J Med"},{"key":"1282_CR55","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","volume":"66","author":"P M\u00f8ller","year":"2017","unstructured":"M\u00f8ller P, Sepp\u00e4l\u00e4 T, Bernstein I et al (2017) Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. GUT 66:464\u2013472","journal-title":"GUT"},{"key":"1282_CR56","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","volume":"378","author":"J Burn","year":"2011","unstructured":"Burn J, Gardes AM, Macrae F et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378:2081\u20132087","journal-title":"Lancet"},{"key":"1282_CR57","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","volume":"28","author":"DJ Sargent","year":"2010","unstructured":"Sargent DJ, Marsoni S, Monges G et al (2010) Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 28:3219\u20133226","journal-title":"J Clin Oncol"},{"key":"1282_CR58","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/annonc\/mdu100","volume":"25","author":"J Goldstein","year":"2014","unstructured":"Goldstein J, Tran B, Ensor J et al (2014) Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol 25:1032\u20131038","journal-title":"Ann Oncol"},{"key":"1282_CR59","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN et al (2017) Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357:409\u2013413","journal-title":"Science"},{"key":"1282_CR60","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL et al (2017) Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 18:1182\u20131191","journal-title":"Lancet Oncol"},{"key":"1282_CR61","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM et al (2018) Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol 36:773\u2013779","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-018-1282-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T19:31:54Z","timestamp":1604259114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-018-1282-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1282"],"URL":"https:\/\/doi.org\/10.1007\/s10147-018-1282-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"13 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that he has no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}